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ABSTRACT
Objectives: Evaluate the time dependent expression of genes in preterm neonates and verify the influence of ontogenic 
maturation and the environmental factors on the gene expression after birth. 
Material and methods: The study was carried out on 20 full-term newborns and 62 preterm newborns (mean birth 
weight = 1002 [g] (SD: 247), mean gestational age = 27.2 weeks (SD: 1.9)). Blood samples were drawn from all the study 
participants at birth and at the 36th week postmenstrual age from the preterm group to assess whole genome expression 
in umbilical cord blood and in peripheral blood leukocytes, respectively. (SurePrint G3 Human Gene Expression v3, 8x60K 
Microarrays (Agilent)). 
Results: A substantial number of genes was found to be expressed differentially at the time of birth and at 36 PMA in 
comparison to the term babies with more genes being down-regulated than up-regulated. However, the fold change in the 
majority of cases was < 2.0. Extremely preterm and very preterm infants were characterized by significantly down-regulated 
cytokine and chemokine related pathways. The number of down-regulated genes decreased and number of up-regulated 
genes increased at 36 PMA vs. cord blood. There were no specific gene expression pathway profiles found within the groups 
of different gestational ages.
Conclusions: Preterm delivery is associated with a different gene expression profile in comparison to term delivery. The 
gene expression profile changes with the maturity of a newborn measured by the gestational age. 
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INTRODUCTION
Progress in the development of intensive care achieved 
in the past few decades has resulted in an increased survival 
of the smallest infants. However, the improved survival of 
very low birth weight (VLBW) infants has led to an increased 
rate of complications, which is the underlying reason for 
a higher rate of infant mortality and morbidity [1–4]. 
Complications of prematurity such as bronchopulmo-
nary dysplasia (BPD) or retinopathy of prematurity (ROP) 
are considered to be complex diseases and their patho-
genesis depends on the interaction of a susceptible host 
with a multitude of environmental risk factors [5, 6]. The 
most important risk factor for BPD or ROP is the degree of 
maturity of the newborn. However, the environmental fac-
tors like prenatal and postnatal infection, oxygen exposure, 
postnatal nutrition and weight gain, drugs and many others 
can modify the course of the disease [7, 8]. Due to the com-
plexity of these interactions studying the complications of 
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prematurity is very difficult. The development of the tools 
that can evaluate many different genetic and environmental 
factors simultaneously is of crucial importance for future 
progress in our understanding of the pathogenesis and the 
pathomechanism of complications of prematurity.  
Introduction of the microarray techniques to clinical 
studies was one of the most important turning points re-
sulting in a dramatic progress in the field of human genetics 
during the last decade [9]. RNA-microarray allows analyzing 
the expression of all human genes. Computational methods 
of analyzing vast amounts of data are continuously being 
developed and quantitative tools for analyzing networks are 
now also more accessible. Microarrays can be used to study 
associations between genetic variations and occurrences 
of diseases, searching for cancer susceptibility markers, 
molecular karyotyping and pharmacogenomics [10]. The 
greatest advantage of this method is its ability to assess 
a great number of genetic factors and requires only a small 
amount of blood for testing, which is very important aspect 
when handling preterm neonates.
In this study the gene expression profiles in preterm 
infants born before 30 weeks of gestation were explored 
in order to evaluate the time dependent expressions of 
genes in preterm neonates and to verify whether the on-
togenic maturation and environment factors can influence 
the genes expression after birth. 
MATERIAL AND METHODS
A prospective study was conducted between Septem-
ber 1st, 2013, and November 30th, 2015. Two cohorts of 
children were collected: a preterm group and a control 
group that comprised term newborns. The enrollment 
of preterm children was divided into three subgroups: 
subgroup 1 — newborns born ≤ 26 weeks of gestation, 
subgroup 2 — newborns born between 27 and 28 weeks 
of gestation and subgroup 3 — newborns born between 
29 and 30 weeks of gestation. The control group included 
healthy, full term newborns. All preterm children were born 
in the level III perinatal center and all control children were 
born in the level I city hospital.
Detailed perinatal history (birth weight, gestational age) 
and maternal history were recorded after birth. Appropriate 
Ethics Committee approved the study. An informed written 
consent was obtained from every parent before the birth of 
participant involved in the study.
Microarray analysis
Blood samples were drawn from all the study partici-
pants at birth and at the 36th week postmenstrual age in 
the preterm group  to assess the whole genome expression 
in umbilical cord blood and in peripheral blood leukocytes, 
respectively.
The density gradient centrifugation with Histo-
paque-1077 (Sigma-Aldrich) was performed for 30 min, 
2100 rpm and at a room temperature. The interphase con-
taining the mononuclear cells was collected to a new tube, 
washed two times in 1x PBS (Phosphate-Buffered Saline, 1x 
wo calcium and magnesium; Corning) followed by centrifu-
gation 10 min, 1600 rpm, room temperature. Finally, pel-
leted MNCs (Mononuclear Cells) were suspended in 1x PBS 
solution. The final volume of the PBS suspension matched 
the starting volume of the processed blood (0.25–0.95 mL).
Subsequently, total RNA was extracted by RiboPure 
Blood Kit (Ambion, Thermo Fisher Scientific, Carlsbad, Cali-
fornia, USA) and quantified by spectrophotometry (Na-
noDrop ND-1000; Thermoscientific, Waltham, USA). RNA 
quality and integrity was determined by 2100 Bioanalyzer 
(Agilent, Santa Clara, USA). For the single microarray experi-
ment 50 ng of total RNA was used.
To study the whole genome expression with a com-
prehensive coverage of genes and transcripts SurePrint 
G3 Human Gene Expression v3, 8x60K Microarrays (Agilent, 
Santa Clara, USA) were used. Microarray gene expression 
experiment was performed according to the manufacturer’s 
protocol (Two-Color Microarray-Based Gene Expression 
Analysis — Low Input Quick Amp Labeling ver.6.9.1). After 
experiment, the arrays were scanned by SureScan Microar-
ray Scanner (Agilent, Santa Clara, USA) and data was ex-
tracted using Feature Extraction Software (Agilent, Santa 
Clara, USA).
Predefined comparisons
The following gene expression comparisons were 
planned: 
 Ū newborns born ≤ 26 weeks of gestation (extremely pre-
term) vs. full term, 
 Ū newborns born between 27–28 weeks of gestation (very 
preterm) vs. full term,
 Ū newborns born between 29–30 weeks of gestation 
(moderately preterm) vs. full term,
 Ū newborns born ≤ 26 weeks of gestation (extremely 
preterm) vs. newborns born between 27–28 weeks of 
gestation (very preterm),
 Ū newborns born ≤ 26 weeks of gestation (extremely 
preterm) vs. newborns born between 29–30 weeks of 
gestation (moderately preterm),
 Ū newborns born between 27–28 weeks of gestation (very 
preterm) vs. newborns born between 29–30 weeks of 
gestation (moderately preterm).
These comparisons were performed at two time points 
(at birth and at 36th week postmenstrual age — PMA). More-
over, the gene expression profile at birth was compared to 
the gene expression profile assessed at the age of 36 weeks 
PMA for each preterm newborn. 
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Statistical analysis
Quality control was performed by investigating Prin-
cipal Component Analysis (PCA). None of the arrays were 
discarded due to poor quality. A moderated t-test was 
used to compare the differences between the groups [11]. 
Multiple testing correction was applied using the Benjami-
ni-Hochberg procedure to control the false discovery rate 
(FDR). A probe set with a corrected for multiple comparisons 
p-value < 0.05 was considered as significantly differentially 
expressed. 
DAVID annotation tools were used to explore which 
predefined gene sets were significantly enriched between 
the study groups [12, 13]. The KEGG (Kyoto Encyclopedia of 
Genes and Genomes; www.genome.jp/kegg) and Biocarta 
pathways (www.biocarta.com) were selected for analy-
sis. Genes differentially expressed between the groups with 
p-values adjusted for multiple testing < 0.05 and with fold 
change (FC) > 2.0 were used as input for pathway enrich-
ment analysis in DAVID.
RESULTS
Sixty-two preterm and twenty full-term newborns 
were included in the study. The mean birth weight of new-
borns in the preterm cohort was 1002 g (SD: 247), and the 
mean gestational age was 27.2 weeks (SD: 1.9). The clinical 
characteristics of the preterm subgroups are presented in 
Table 1. The control group included 10 girls and 10 boys, all 
with birthweight between 2500 and 4000 grams.
Comparison of the cord blood gene expression 
profiles between preterm subgroups  
vs. full term newborns
The number of significantly over- and under-expressed 
probes was 8362 in the extremely preterm children, 11180 in 
the very preterm and 8152 in the moderately preterm group. 
These numbers represent 5752, 7640 and 5745 genes, re-
spectively. However, the fold change in majority of the cases 
was < 2.0. Only genes with FC ≥ 2 were used for pathway 
analysis and the results of these evaluations were presented 
in Table 2. The pathway enrichment analysis recognized 
only two pathways (hsa04060: Cytokine-cytokine receptor 
interaction and hsa04062: Chemokine signaling pathway), 
which were down-regulated in the group of extremely pre-
term infants compared to the group of full-term children. 
No pathway was up-regulated among extremely preterm 
children. Similar results were found in the group of very 
preterm children. The same two pathways were significantly 
down-regulated (hsa04060: Cytokine-cytokine receptor in-
teraction and hsa04062: Chemokine signaling pathway) 
and none was up-regulated. In the group of moderately 
preterm children one pathway was up-regulated (hsa04612: 
Antigen processing and presentation) and no pathway was 
down-regulated.
Comparison between the gene expression profiles 
from peripheral blood leukocytes sampled at the age of 
36th week PMA in the preterm children and from the um-
bilical blood of full-term infants revealed 9960, 12178 and 
Table 1. The clinical characteristics of the population of preterm newborns
Extremely preterm (n = 19) Very preterm (n = 23) Moderately preterm (n = 20)
Male/female 8/11 6/17 9/11
Birth weight (g); mean (SD) 786 (125) 969 (155) 1246 (211)
Gestational age (weeks); mean (SD) 25 (1.0) 27.5 (0.5) 29 (1)
Prenatal steroids 14 (74%) 20 (87%) 14 (70%)
Oxygen at 28 day of life 19 (100%) 14 (60%) 6 (30%)
Oxygen at 36 PMA 3 (16%) 0 1 (5%)
Laser coagulation treatment due to 
retinopathy of prematurity 4 (21%) 1 (4%) 0
PMA — postmenstrual age
Table 2. Comparison between gene expression profile from umbilical blood leukocytes sampled at birth in preterm children and in full-term infants
Extremely preterm (n = 19) Very preterm (n = 23) Moderately preterm (n = 20)
Probes Genes Probes Genes Probes Genes
FC > 2.0 Up-regulated 269 188 379 274 285 233
Down-regulated 504 362 755 562 347 275
FC — fold change
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9229 differentially expressed probes and 6573, 7893 and 
6275 differentially expressed genes. The numbers of the 
most significantly differentially expressed probes and genes 
are presented in Table 3.
The pathway enrichment analysis did not show any 
differentially down-regulated pathways in the group of 
extremely preterm infants in comparison to the group 
of full-term children. However, hsa04668: TNF signaling 
pathway was up-regulated among the extremely preterm 
children. There were no down-regulated or up-regulated 
pathways found in the groups of very preterm children. The 
hsa04668: TNF signaling pathway was found up-regulated 
and no pathway was down-regulated in the moderately 
preterm infants.
Comparison of the gene expression profiles  
at birth and at the age of 36th week PMA
The summary of the differentially expressed probes 
and genes between the birth time and the age of 36th week 
PMA is presented in Table 4. In extremely preterm children, 
among the genes with a fold change > 2.0, the expres-
sion of 538 probes (384 genes) decreased from birth to 
36 weeks PMA and the expression of 457 probes (285 genes) 
increased between the two time points. No pathway was 
up-regulated at 36 PMA in comparison to the cord blood 
and 4 pathways were found down-regulated: hsa04510: 
Focal adhesion; hsa04611: Platelet activation; hsa04726: 
Serotonergic synapse and the hsa00590: Arachidonic acid 
metabolism pathway.
In very preterm children, among the genes with a fold 
change > 2.0, the expression of 536 probes (419 genes) de-
creased from birth to 36 weeks PMA and the expression of 
1654 probes (1095 genes) increased between the two time 
points. No pathway was up-regulated at 36 PMA as com-
pared to the cord blood and 1 pathway was down-regulated: 
hsa00590: Arachidonic acid metabolism.
In moderately preterm children, among the genes with 
a fold change > 2.0, the expression of 146 probes (99 genes) 
decreased from birth to 36 weeks PMA and the expression 
of 743 probes (481 genes) increased between the two time 
points. One pathway was up-regulated at 36 PMA as compared 
to cord blood (hsa04668: TNF signaling pathway) and two 
pathways were down-regulated (hsa04062: Chemokine signal-
ing pathway; hsa04612: Antigen processing and presentation).
Comparison of gene expression between 
subgroups of preterm infants
Analysis of gene expression of the umbilical blood 
has shown no differences between the extremely preterm 
vs. moderately preterm groups and between the very pre-
term vs. moderately preterm groups. However, 88 probes 
(66 genes: 33 down-regulated and 33 up-regulated) were 
differentially expressed in the extremely preterm groups in 
comparison to the very preterm groups. No other pathways 
were differentially expressed.
Different situation was found at the 36th PMA week. 
4109 probes (3146 genes) were differentially expressed 
between extremely preterm and very preterm groups, 
4856 probes (3405 genes) between extremely preterm and 
moderately preterm groups and 80 probes (54 genes) be-
tween very preterm and moderately preterm groups. How-
ever, the differences in expression of only a few genes were 
higher than twofold (Table 5).
Pathway analysis has shown no differences between 
the extremely preterm and very preterm groups, extremely 
preterm and moderately preterm groups and between the 
very preterm and moderately preterm groups. 
DISCUSSION
In this study, we compared the results of whole genome 
expression profiles of cord blood and blood collected at the 
age of 36 weeks PMA from children born before 30 weeks of 
Table 3. Comparison between gene expression profiles from peripheral blood leukocytes sampled at the age of 36th week postmenstrual age 
(PMA) in preterm children and from umbilical blood of full-term infants
Extremely preterm (n = 19) Very preterm (n = 23) Moderately preterm (n = 20)
Probes Genes Probes Genes Probes Genes
FC > 2.0 Up-regulated 596 377 328 204 274 165
FC > 2.0 Down-regulated 113 75 115 83 87 55
FC — fold change
Table 4. The summary of the number of differentially expressed 
probes and genes between samples collected at birth and at the 
age of 36th week PMA
Probes Genes
Any FC FC > 2.0 Any FC FC > 2.0
Extremely preterm 
(n = 19) 16862 995 10589 669
Very preterm 
(n = 23) 16311 2190 10434 1514
Moderately preterm 
(n = 20) 8581 889 5866 580
FC — fold change 
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gestation. The nature of the study was mainly exploratory, 
without any formal specific hypothesis to be verified. How-
ever, some predefined assumptions based on the selected 
group of patients can be made. Firstly, one can expect that 
preterm delivery would be associated with different gene 
expression profile in comparison to term delivery. Secondly, 
the gene expression profile may change with the maturity of 
a newborn measured by the gestational age. And finally, the 
expression of the genes in a referral time point represented 
by 36 PMA should be more or less similar for preterm babies. 
There is a general agreement that term labor may be 
considered an inflammatory process that is associated with 
an increased expression of genes coding for pro-inflamma-
tory cytokines, which starts the process of decidual activa-
tion. Localized inflammation leads to decidual disruption 
and might be one of the causes of preterm delivery. We 
considered this assumption as a sufficient rationale for our 
study. We were also aware that using cord blood for microar-
ray analysis requires extrapolation of the results on the gene 
expression profile at the site of maternal fetal interphase. 
Comparison of gene expression profile between 
preterm subgroups vs. full term newborns
The first observation is that there is a substantial dif-
ference between the gene expression profile at birth for 
infants born before 30 weeks of gestation and full-term 
children. Most of the genes in preterm newborns were 
under-expressed in comparison to the group of mature chil-
dren. The difference in expression levels of more than 90% 
of these genes was only mildly to moderately significant 
(fold change < 2.0). We performed detailed analysis of the 
genes with FC > 2.0 via the pathway enrichment analy-
sis. This method can detect transcriptional programs that 
are distributed across an entire network of genes, yet are 
subtle at the level of individual genes. Using this method 
we found two pathways (Cytokine-cytokine receptor in-
teraction and Chemokine signaling pathway), which were 
differentially regulated between both groups at the day 
of birth. Cytokine-cytokine receptor interaction pathway 
is responsible for intercellular signaling, controlling cell 
growth and differentiation, cell death, angiogenesis and 
host defense. Among the genes involved in this pathway are 
interleukins (IL1A, IL1B, IL23A, IL6, IL8, IL15), chemokines, 
TNF and TNF receptors superfamily. During our study, we 
detected several genes from these pathways, which were 
down regulated in the preterm group versus the term 
babies. The study of expression of different CC and CXC 
chemokines in choriodecidual and maternal blood was per-
formed in groups of term not in labor (TNF), term in labor 
(TL), idiopathic preterm labor (PTL) and preterm labor as-
sociated with infection (PTLI) [14]. Among differentially ex-
pressed chemokines, all of the groups revealed significant 
up-regulation in the TL vs. TNL. Comparison of PTL with TNL 
also showed an up-regulation of all the chemokines, except 
CCL16 (Fold change –14.4) and CCL19 (FC –1.8). It should 
be emphasized, however, that FC values for all up-regu-
lated chemokines in these comparisons were significantly 
lower than those observed in TL vs. NTL (e.g.: 7.3 vs. 25.9; 
27.2 vs. 35.1; 17.9 vs. 44.5). Even, if authors did not perform 
a direct comparison of PTL vs. TL, based on the above results 
we can expect down regulation of chemokines in the PTL in 
comparison to the term labor (TL). This finding corroborates 
our results on the down-regulation of cytokine-cytokine 
receptor interactions and chemokine pathways in the PTL 
in comparison to TL. In the aforementioned study ten out of 
12 CC and CX cytokines validated by PCR were significantly 
up-regulated in the TL vs. TNL group. The comparison of 
the preterm labor vs. term not in labor showed up-regu-
lation in 5 chemokines (CCL4,5,8 and CXCL1,6), but only 
the CCL8 up-regulation was associated with the increased 
protein level. However, the level of significance for the 
up-regulation of PTL vs. TNL was 5-fold lower in comparison 
with TL vs. TNL (p < 0.05 vs. p < 0.01). Six chemokines did not 
show statistically significant differences. These also support 
the concept that a comparison with the TL should result in 
a down-regulation of the chemokine expression in the PTL. 
The analysis of chemokines in maternal plasma revealed 
that only CXCL8 chemokine was present in higher concen-
trations among mothers with TL vs. TNL and PTL vs. PTNL. 
CCL5 levels were higher in the PTL vs. PTNL but not vs. TL. 
CXCL10 was significantly higher in the TL vs. PTL. Generally, 
these results show a differential gene expression profile in 
the maternal decidua and maternal blood during preterm 
delivery, which does not contradict our results. There are, 
however, several important points that should be men-
tioned. Firstly, the sample size of the PTL was significantly 
Table 5. Comparison of gene expression between subgroups of preterm infants
Extremely preterm  
vs. very preterm
Extremely preterm  
vs. moderately preterm
Very preterm  
vs. moderately preterm
Probes Genes Probes Genes Probes Genes
FC > 2.0 Up-regulated 17 16 5 5 0 0
FC > 2.0 Down-regulated 13 12 431 292 0 0
FC — fold change
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lower than our group (20 vs. 62) and the authors did not 
provide any information about gestational age of preterm 
babies. Secondly, a high percentage of mothers in our 
preterm group received treatment with prenatal steroids 
(DxM) before delivery, which may inhibit the expression of 
chemokines in the cord blood. This was confirmed by the 
same authors who performed the analysis of chemokine ex-
pression profile in the choriodecidual explants treated with 
bethamethasone [14]. They found that CCL3, CCL4, CCL5, 
CXCL8 and CXCL10 were significantly down-regulated by 
dexamethasone treatment. Only CCL2 expression remained 
unaltered by the treatment. Finally, we can assume that 
both study groups show high preterm delivery etiologic 
heterogeneity, which is not easy to identify at the moment.
It was also interesting that among all the down regu-
lated genes at the time of birth 198 genes were common 
for all three groups of preterm infants. The number of genes 
uniquely expressed by a specific gestational age group was 
as follows: GA ≤ 26 wks (69), GA 27–29 wks (227) and GA 
29–30 wks (13) (Figure 1). The common genes may represent 
determinants that are down-regulated in a manner that is 
not dependent on the gestational age. Inspecting the gene 
list reveals several interesting groups that can be identified:
 Ū chemokine and ILR,
 Ū G-protein signaling,
 Ū long intergenic non-protein coding RNA,
 Ū growth factors.
Comparison of the gene expression profile  
at birth and at the age of 36 week PMA
We found a large number of differentially expressed genes 
between the two time points. Analysis showed that the ex-
pression of about one third of the genome changed between 
birth and 6–12 weeks after birth. The difference in the expres-
sion fold change in the majority of genes ranged between 
1.5 and 2.0, however, the expression of 285–1095 genes in-
creased by twofold. The pathway analysis has shown 7 dif-
ferentially regulated pathways between the two time-points.
Interestingly, there were more differentially expressed 
genes up-regulated in the group of preterm babies tested 
at the age of 36th PMA. The pathway analysis revealed only 
the TNF signaling pathway, which was repeated in extremely 
and moderately preterm groups. At the 36 PMA the group of 
up-regulated genes, that is common for three preterm catego-
ries, comprises 115 genes. However, among the genes specifi-
cally overexpressed in each GA category, the majority of genes 
were observed in the extremely preterm babies (n = 195), 
whereas in the groups of very preterm and moderately pre-
term the numbers were significantly lower: n = 12 and n = 22, 
respectively (Figure 2). The pool of genes specific for the first 
group (GA ≤ 26 weeks) includes genes that are involved in:
 Ū the mitotic cell activity represented by cyclin A2, cyclin 
dependent kinase, cell division cycle 34, G1 to S1 tran-
sition,
 Ū DNA repair mechanisms: growth arrest and DNA dam-
age inducible alpha, RAD23 homolog A nucleotide exci-
sion repair protein,
 Ū growth factors: growth differentiation factor, insulin 
like growth factor 2 mRNA binding protein, Kruppel like 
factor 1, BMP2 inducible kinase,
 Ū mechanism of ubiquitination: ubiquitin B, ubiquitin 
conjugating enzyme E2, ubiquitin domain containing 1.
All these groups might reflect the processes represent-
ing acceleration of growth of the extremely immature in-
fants, “trying” to catch up. 
The numbers of genes, which were still down-regulated 
at the 36 PMA were 75, 83 and 55 for extremely, very and 
moderately preterm infants, respectively (Figure 3). A group 
of 32 down-regulated genes, shared by all the three groups, 
includes: the member of TNFR superfamily, chemokine re-
ceptor 5 and 6 and prostaglandin reductase. In comparison 
to the cord blood, there are no genes which continue to 
be down-regulated by the 36 PMA. Overall, the number 
of shared genes, which were down-regulated at birth, was 
reduced at the 36 PMA (from 198 to 32). It suggests that the 
Figure 1. Comparison of the number of genes with decreased 
expression (fold change greater than 2.0) in the umbilical blood
69
84
198
11
227
13
53
GA < 26 weeks
GA 27–28 weeks
GA 29–30 weeks
Figure 2. Comparison of the number of genes with increased 
expression (fold change greater than 2.0) at the 36 week 
postmenstrual age
195
58
115
9
12
22
19
GA < 26 weeks
GA 27–28 weeks
GA 29–30 weeks
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diminished number of down-regulated genes reflects the 
dynamic metabolic processes occurring between the birth 
and the 36 PMA and that at this age these children are ap-
proaching the maturity state of normal term babies. Based 
on the number of down-regulated genes, one can speculate 
that the extremely and very preterm babies still need more 
time to attain expression profile similar to the full term 
newborns. The fact that we were unable to find any specific 
pattern or pathway that would be significantly down-regu-
lated at 36 PMA for any GA category, forefend building any 
reasonable hypothesis about specific mechanisms taking 
part in the maturation of preterm babies. 
Comparison of gene expression in the cord 
blood between subgroups of preterm infants
Interestingly, we have not found any differences in gene 
expression between preterm infant subgroups in the cord 
blood. The explanation of this is challenging, especially con-
sidering that we have found a lot of differentially expressed 
genes in the blood collected at the 36th week PMA. On the 
other hand, the difference was moderate and the expression 
of only a few genes was higher than twofold. These genes, 
however, did not show any specific pattern and no significant 
differentially expressed pathway was observed. A possible 
explanation is that the preterm labor is a very complex pro-
cess associated with the interaction of many factors within 
a delicate network. Genes and gene products involved in this 
network might represent small effects, which are not suffi-
cient to be “picked up” by rigorous statistical analysis. It may 
also imply that the gene expression profile during preterm 
delivery does not depend on the gestational age and repre-
sents a similar response to different extrinsic (e.g. infection) 
and intrinsic (maternal diseases, metabolic, stress etc.) trigger 
factors. The other probable explanation is that using only the 
cord blood may not reflect the true gene expression profile 
present in maternal tissue, such as decidua or placenta. 
A Spanish group conducted a prospective cohort study 
comparing preterm (27–36 GA) or term (> 37 wks) deliveries 
after a threatened preterm labour with term deliveries with-
out suspected preterm labour [15]. They used placental sam-
ples for mRNA analysis and cord blood for selected protein 
inflammatory markers. Both groups of preterm delivery and 
term delivery after suspected preterm labour revealed an in-
creased expression of TNF alpha, IL6 and PGF. The expression 
profiles of IFN gamma and VEGFR1 were decreased. Protein 
markers in the cord blood showed only an increased expres-
sion of TNF alpha and PGF. The other protein markers did not 
show any differences between the studied groups. This may 
suggest that expression profile in the cord blood does not 
fully reflect the profile observed in-situ [15]. 
An experimental study on fibroblast culture of term 
decidual cells obtained from uncomplicated term preg-
nancies after elective CS and before the onset of labor was 
performed by the group from The Ohio State University [16]. 
After fibroblast challenge with IL1 beta for 6 hours up-regu-
lation 448 transcripts and down-regulation of 116 transcripts 
was observed. Among highly up-regulated transcripts 
were pro-inflammatory cytokines (TNF, IL1A IL6), different 
chemokines and prostaglandin synthesizing enzymes. Path-
way enrichment analysis provided cytokine-cytokine recep-
tor interaction, apoptosis, Janus kinase signal transducer 
and STAT signaling [16]. This study supports the concept 
of up-regulation of genes involved in pro-inflammatory 
pathways at the time of delivery. It is, however, difficult to 
directly relate our results indicating on down-regulation 
of cytokine and chemokine related pathways to the above 
experimental studies because of the applied intervention 
with pro-inflammatory cytokine IL1 beta.
NICHD, NIH studies carried out by [17] focused on the 
transcriptome analysis of samples from chorio-amniotic 
membranes and blood taken from mothers at term with 
no labor (TNL) and term in labor (TIL) of uncomplicated 
pregnancy. The authors have found 197 transcripts which 
were significantly different between both groups. After gene 
ontology analysis TIL women revealed significant overex-
pression of multiple chemokines, neutrophil and monocyte 
recruitment pathways in chorioamniotic membranes. How-
ever, transcription profiling of the blood samples did not 
reveal any Gene Ontology enrichment category. This may 
indicate that human spontaneous labor without histologic 
signs of chorioamnionitis is characterized by a significant 
acute inflammatory response and that blood transcriptome 
may not fully correlate with in-situ gene expression profiling. 
CONCLUSIONS
1. There is a substantial number of differentially expressed 
genes at the time of birth and at 36 PMA in compari-
Figure 3. Comparison of the number of genes with decreased 
expression (fold change greater than 2.0) at the 36 week 
postmenstrual age
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son with the term babies with more genes that are 
down-regulated than up-regulated.
2. Extremely and very preterm infants are characterized by 
significantly down-regulated cytokine and chemokine 
related pathways, which might reflect different preterm 
labor factors. Also, the effect of prenatal steroids cannot 
be excluded.
3. The decreasing number of down-regulated genes and 
the increasing number of up-regulated genes at 36 PMA 
vs. cord blood suggest that this is the time when preterm 
babies are approaching the state of maturity of term 
newborns. However, there is no specific pattern among 
these genes. Four down-regulated pathways, including 
arachidonic acid metabolism and one up-regulated (TNF 
signaling), may reflect the iatrogenic effects of intensive 
treatment of different morbidities, typically occurring in 
these groups of infants.
4. The lack of specific gene expression profile pathways 
within the groups of different GA may suggest activity of 
minor genes of small additive effects, rather than genes 
with major effects on the time of preterm delivery, which 
belong to the same pathway. This appears to be sup-
ported by the fact that all three groups shared nearly 
200 down-regulated genes, whereas the groups of ex-
tremely and very preterm infants had 209 down-regu-
lated genes in common, which represents factors that 
are not dependent on GA.
5. It should be kept in mind that the expression profile 
based on the cord blood may show weak correlation 
with the in-situ genes expressions.
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